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Available online 14 January 2016Hermansky–Pudlak syndrome type 2 (HPS2) is a rare autosomal recessive disorder resulting from functionalmu-
tations in the adaptor-related protein complex 3, beta 1 subunit (AP3B1) gene. This gene plays a role in organelle
biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Here we describe the genera-
tion of anHPS2 iPS cell line (CHOPHPS2) using a Cre-excisable polycistronic STEMCCA lentivirus. This linewas de-
rived from human ﬁbroblasts isolated from a patient carrying two mutations in the AP3B1 gene. The patient
presented with severe neutropenia, ocular albinism, interstitial pulmonary ﬁbrosis, hemorrhagic diathesis, and
an absence of platelet-dense granules.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource table: CHOPHPS2Name of stem cell construct CHOPHPS2stitution The Children's Hospital of Philadelphia (CHOP)
erson who created resource Lin Lu
ontact person and email Deborah L. French, frenchd@email.chop.edu
ate archived/stock date 2012
rigin Human skin ﬁbroblasts (GM17890, Coriell Cell
Repositories)
pe of resource Biological reagent: iPSC derived from human
skin ﬁbroblasts
btype Cell Line
ey transcription factors Oct4, Sox2, Klf4, c-Myc
uthentication Identity and purity of cell line conﬁrmed (Fig. 1)
nk to related literature Huizing et al., 2002
formation in public databases N/AInResource details
Human skinﬁbroblasts isolated from a 4-year-oldmale HPS2 patient
were obtained from the Coriell Cell Repositories (Camden, NJ). The pa-
rental line, GM17890, carries a compound heterozygous mutation in
the AP3B1 gene: C1578T (R508X) in exon 15 and G2028T (E659X) in
exon 18. The cells were transduced with a STEMCCA Cre-excisable Con-
stitutive Polycistronic lentivirus expressing Oct4, Klf4, Sox2, and c-myc.
Cre-mediated excision of the vector following reprogramming was
demonstrated (Fig. 1A). Themutationwas validated byDNA sequencingMolecular Therapeutics, The
. This is an open access article underand quantitative PCR (qPCR) (Fig. 1B). The cells exhibited a normal
karyotype (46, XY) upon G-band analysis (Fig. 1C).
Pluripotency was veriﬁed by gene expression of stem cell markers
DMNT3B, REX1, ABCG2, OCT4, NANOG, and SOX2 using qPCR (Fig. 1E).
In addition, expression of pluripotent surface markers at single cell
resolution were conﬁrmed by ﬂow cytometry (Fig. 1D). Differentiation
capacity into three germ layers was conﬁrmed by in vivo teratoma
formation (Fig. 1F).
Materials and methods
Cell culture and iPSC reprogramming
Human HPS2 ﬁbroblast line, GM17890, was cultured in IMDM
(Mediatech) containing 10% FBS at 37 °C and 5% CO2 in a humidiﬁed
incubator. STEMCCA lentiviral vector was produced, and cells were
infected as previously described (Somers et al., 2010). The STEMCCA
Cre-Excisable Constitutive Polycistronic viral vector used for
reprogramming encoded Oct4, Klf4, Sox2, and c-myc. Human ﬁbro-
blasts were incubated with 5–10 μl STEMCCA virus plus 5 μg/ml of
polybrene in ﬁbroblast medium. Six days after infection, cells were
replated on 100-mm dishes containing irradiated mouse embryonic ﬁ-
broblasts (MEFs). The cells were maintained in IMDM with 10% FBS,
NEAA (1%), glutamine (1%), penicillin/streptomycin (1%), 50 μg/ml
ascorbic acid, and 4 ng/ml bFGF for 4 days. Thereafter, cells were main-
tained in human embryonic stem cell medium (HES) containing
4 ng/mL of bFGF. The medium was replenished every 2–3 days for
3 weeks until uniform colonies were generated. The iPSC colonies
were mechanically isolated and expanded on MEFs.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Generation and characterization of CHOPHPS2. (A) Cre-mediated excision of the lentiviral vector in three clones of the CHOPHPS2 iPSC line. Cells from a non-excised lentiviral iPSC
line were used as a positive control. (B) Validation of the HPS2 mutation by DNA sequencing of the AP3B1 gene (exons 15 and 18) and qPCR measurement of gene expression.
(C) Karyotype analysis of CHOPHPS2. (D) Flow cytometry proﬁles of surface markers on undifferentiated cells: SSEA3, SSEA4, TRA-1-60, and TRA-1-81. (E) Quantitative PCR of relative
gene expression of pluripotency genes compared to two embryonic stem cell lines (H9 and H1) and the parental ﬁbroblast line (GM17890). (F) H&E staining of teratoma sections
identifying the three germ layers.
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Transgene removal was performed as previously described (Somers
et al., 2010). Brieﬂy, iPSCs were transfected with 2 μg/well of pHAGE2-
Cre-IRES-PuroR plasmid DNA using Hela Monster transfection reagent
(Mirus, Madison, Wi) according to the manufacturer's instructions.
Cre-excised iPSC colonies were isolated by growth in puromycin
(1.2 μg/ml) selection medium 24 h post-transfection for 48 h. Genomic
DNAwas isolated using theDNeasy Blood& Tissue kit (Qiagen, Valencia,
CA) from each subclone after 2–3 weeks in culture and screened for
hSTEMCCA transgenes using the following primers: OCT4-Tg-F: 5′GGT
GCG CCA GTA AAG CAG ACA TTA AAC3′; KLF4-Tg-R: 5′CAG ACG CGA
ACG TGG AGA AAG A3′ and GAPDH-F: 5′GTG GAC CTG ACC TGC CGT
CT3′; GAPDH-R: 5′GGA GGA GTG GGT GTC GCT GT3′.
Mutation veriﬁcation
PCR ampliﬁcation was performed on genomic DNA isolated from
iPSCs using the referenced primer sets: AP3B1 exon 15, 5′ATAGTTAA
AACCTTTTCTATG3′ and 5′TGATCAGAGTGAAGAGGAAAG3′ AP3B1 exon
18, 5′AGCTTGCTTTTGAATTCAGT3′ and 5′TCTGAGATATAGAATGTAATC3′
(Huizing et al., 2002). Products were sequenced by the CHOP NAPCore
facility. Expression of the mutated AP3B1 gene was shown by qPCR
using the following primers: 5′TTGGTAGCTGGCAGTGTTGTGATG3′ and
5′CCGAGCATATCGAGTTAGCATGTGGA3′.
Karyotype analysis
Chromosomal G-band analyses were performed in the Genomics
Core Laboratory (CHOP).
Flow cytometry analysis
Expression of pluripotency markers were evaluated by ﬂow cytom-
etry using the following antibodies: Alexa-Fluor®-647α-human SSEA4
(1:400) and Tra-1-81 (1:200); Alexa-Fluor®-488 SSEA3 (1:200) and
Tra-1-60 (1:200) (BioLegend). Accutase-dissociated single cells were
analyzed using a FACSCanto ﬂow cytometer (BD Biosciences) and the
FlowJo software program (Tree Star, CA).RT-PCR and quantitative PCR
RNAwas isolated from the CHOPHPS2 iPSCs using the RNeasymicro
kit (Qiagen) according to themanufacturer's instructions. Reverse tran-
scriptionwas performed on total RNA (500 ng) using randomhexamers
and Superscript III Reverse Transcriptase (Life Technologies). RT-qPCR
was performed on a LightCycler-480II (Roche, IN). All experiments
were performed in triplicate using SYBR-Green qPCR supermix
(Roche) according to the manufacturer's instructions. Primers for en-
dogenous genes (DMNT3B, REX1, ABCG2, OCT4, NANOG, and SOX2)
were prepared as previously described (Mills et al., 2013). Humangeno-
mic DNA, diluted in 10-fold increments from 1 to 100 ng/μl, was used to
generate a standard curve to determine PCR efﬁciency and relative gene
expression compared to the housekeeping gene TBP (TATA binding box
protein).
In vivo teratoma formation
CHOPHPS2 cells were cultured in feeder-free conditions and dissoci-
ated using trypsin. Single cells (~106) were resuspended in medium
containing growth-factor reduced matrigel (100 μl of 1:3 dilution in
IMDM) (Corning), and injected subcutaneously in the neck of NOD/
SCID mice. After 6–8 weeks, teratomas were excised and ﬁxed in 4%
phosphate-buffered formalin for 24 h. The ﬁxed samples were parafﬁn
embedded and hematoxylin and eosin (H&E) stained for histological
analysis. This work was approved by the IACUC committee at CHOP.
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